You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

chemotherapy

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Constipation Trial (kiwifruit)

Not yet recruiting
  • Constipation
  • kiwifruit
  • (no location specified)
Jun 7, 2023

Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitor, Radiotherapy Trial (radiation, drug, biological)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • +3 more
  • Intensity Modulated Radiation Therapy
  • +3 more
  • (no location specified)
Jul 11, 2023

Micrometastases in Axillary Lymph Nodes in Breast Cancer,

Completed
  • Micrometastases
  • Neoadjuvant Chemotherapy
  • Sentinel lymph node biopsy, axillary lymph node dissection
  • (no location specified)
Nov 20, 2023

Pancreatic Cancer Stage IV, Chemo-induced Nausea and Vomiting Trial (Thalidomide, Nab paclitaxel, Gemcitabine)

Not yet recruiting
  • Pancreatic Cancer Stage IV
  • Chemotherapy-induced Nausea and Vomiting
  • (no location specified)
Aug 24, 2023

Colorectal Cancer, Chemo Effect Trial in GuangZhou (FOLFOX chemo regimens, Bevacizumab)

Not yet recruiting
  • Colorectal Cancer
  • Chemotherapy Effect
  • GuangZhou, Guangdong, China
    The Sixth Affiliate Hospital of Sun Yat-Sen University
Apr 3, 2023

Cervical Cancer, Induction Chemo, Immunotherapy Trial in Tianjin (Toripalimab)

Recruiting
  • Cervical Cancer
  • +2 more
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Oct 16, 2023

Elderly Patients, Metastatic Lung Cancer Trial in Wuhan (Single drug chemo plus immunotherapy)

Not yet recruiting
  • Elderly Patients
  • Metastatic Lung Cancer
  • Single drug chemotherapy plus immunotherapy
  • Wuhan, Hubei, China
    Hubei Cancer Hospital
Sep 15, 2023

Esophageal Cancer by AJCC V8 Stage Trial in Zhengzhou (Camrelizumab+Apatinib+Chemotherapy?Camrelizumab+Apatinib,

Recruiting
  • Esophageal Cancer by AJCC V8 Stage
  • Zhengzhou, Henan, China
    The First Affiliated Hospital of Zhengzhou University
Feb 12, 2023

Colorectal Cancer, Liver Metastases, Circulating Tumor Cell Trial in GuangZhou (Colorectal cancer resection combined with liver

Recruiting
  • Colorectal Cancer
  • +3 more
  • Colorectal cancer resection combined with liver metastasis resection.
  • FOLFOX chemotherapy regimen
  • GuangZhou, Guangdong, China
    The Sixth Affiliate Hospital of Sun Yat-Sen University
Apr 14, 2023

TNBC - Triple-Negative Breast Cancer Trial (Camrelizumab Plus Chemotherapy and Famitinib, Camrelizumab Plus Chemotherapy)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Camrelizumab Plus Chemotherapy and Famitinib
  • Camrelizumab Plus Chemotherapy
  • (no location specified)
Aug 17, 2023

Breast Cancer, Chemo Effect Trial (Epirubicin, Cyclophosphamide, Xihuang Pill, Docetaxel, Epirubicin, Cyclophosphamide,

Not yet recruiting
  • Breast Cancer
  • Chemotherapy Effect
  • Epirubicin, Cyclophosphamide, Xihuang Pill, Docetaxel
  • Epirubicin, Cyclophosphamide, Docetaxel
  • (no location specified)
Jun 21, 2023

Sintilimab and Anlotinib in Combination With Chemo Trial in Xi'an (Sintilimab and anlotinib in combination with chemo)

Completed
  • Sintilimab and Anlotinib in Combination With Chemotherapy
  • Sintilimab and anlotinib in combination with chemotherapy
  • Xi'an, Shanxi, China
  • +1 more
Aug 27, 2023

Chemo-induced Nausea and Vomiting, Pediatric Cancer Trial in Ankara (guided imagery)

Recruiting
  • Chemotherapy-induced Nausea and Vomiting
  • Pediatric Cancer
  • guided imagery
  • Ankara, Turkey
    Hacettepe University İhsan Doğramacı Hospital
Nov 2, 2023

Locally Advanced Nasopharyngeal Carcinoma Trial in Guangzhou (2 cycles induction chemo, 3 cycles induction chemo)

Recruiting
  • Locally Advanced Nasopharyngeal Carcinoma
  • 2 cycles induction chemotherapy
  • 3 cycles induction chemotherapy
  • Guangzhou, Other (Non U.s.), China
    First Affiliated Hospital, Sun Yat-Sen University
May 6, 2023

Cancer, Chemo Effect, Quality of Life Trial (Mobile-health self management)

Not yet recruiting
  • Cancer
  • +3 more
  • Mobile-health self management
  • (no location specified)
May 27, 2023

TNBC - Triple-Negative Breast Cancer Trial (epirubicin,cyclophosphamide,paclitaxel,Carrelizumab,

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • (no location specified)
May 8, 2023

Esophageal Squamous Cell Carcinoma Trial in Nanjing (Carrelizumab, Paclitaxel injection, Cisplatin)

Enrolling by invitation
  • Esophageal Squamous Cell Carcinoma
  • Nanjing, China
    The First Affiliated Hospital of Nanjing Medical University
Sep 19, 2023

Gastric Cancer Trial in Xi'an (dietary supplement, biological, drug)

Recruiting
  • Gastric Cancer
  • Taurine
  • +4 more
  • Xi'an, Shaanxi, China
    Tang-Du Hospital
Nov 2, 2023

Gastrointestinal Neuroendocrine Carcinoma Trial in Beijing (Durvalumab and Chemotherapy(oxaliplatin and capecitabine))

Recruiting
  • Gastrointestinal Neuroendocrine Carcinoma
  • Durvalumab and Chemotherapy(oxaliplatin and capecitabine)
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Oct 1, 2023

High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai

Recruiting
  • High-risk Stage II Colorectal Cancer
  • +2 more
  • mFOLFIRINOX adjuvant chemotherapy
  • mFOLFOX6/XELOX adjuvant chemotherapy
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 12, 2023

Tislelizumab Combined With Chemotherapy in First-line Treatment

Active, not recruiting
  • Tislelizumab
  • +3 more
  • Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Sep 6, 2023

Peritoneal Metastases From Colorectal Cancer Trial in Milano (Pressurized intraperitoneal aerosol chemo (PIPAC))

Recruiting
  • Peritoneal Metastases From Colorectal Cancer
  • Pressurized intraperitoneal aerosol chemotherapy (PIPAC)
  • Milano, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Oct 16, 2023

Gynecologic Cancer, Chemo-induced Peripheral Neuropathy Trial in Durham (Cryotherapy, Compression)

Not yet recruiting
  • Gynecologic Cancer
  • Chemotherapy-induced Peripheral Neuropathy
  • Cryotherapy
  • Compression
  • Durham, North Carolina
    Duke University Medical Center
Nov 15, 2023

Radiotherapy, Immunotherapy, Liver Metastases Trial in Shanghai (SBRT, Chemotherapy, PD-1 antibody)

Recruiting
  • Radiotherapy
  • +3 more
  • SBRT
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 2, 2023

Advanced Mucosal Melanoma Trial (Envafolimab combined with recombinant human endostatin and first-line chemo)

Not yet recruiting
  • Advanced Mucosal Melanoma
  • Envafolimab combined with recombinant human endostatin and first-line chemotherapy
  • (no location specified)
Sep 15, 2023